Claudia Wagner

USPTO Granted Patents = 49 (Patent Applications = 28)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 20)

Average Co-Inventor Count = 6.2

ph-index = 9

Forward Citations = 192(Granted Patents)

Location History:

Tübingen, DE (2020 - 2022)
Tuebingen, DE (2018 - 2024)

Company Filing History:

48 out of 725

Immatics Biotechnologies Gmbh

patents

1 out of 1

Emmatics Biotechmiogieg Gmbh

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297252 - T cell receptors with improved pairing (2025-05-13),

2. 12295996 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers (2025-05-13),

3. 12295995 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers (2025-05-13),

4. 12295994 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers (2025-05-13),

5. 12269881 - Antigen binding proteins specifically binding MAGE-A (2025-04-08),

6. 12214025 - Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers (2025-02-04),

7. 12209137 - Antigen binding proteins specifically binding CT45 (2025-01-28),

8. 12188932 - Method for high throughput peptide-MHC affinity screening for TCR ligands (2025-01-07),

9. 12011459 - Methods for manufacturing T cells by direct sorting and compositions thereof (2024-06-18),

10. 11998607 - T cell receptors and immune therapy using the same (2024-06-04),

11. 11932689 - Engineered T cell receptors and immune therapy using the same (2024-03-19),

12. 11859009 - Antigen binding proteins specifically binding PRAME (2024-01-02),

13. 11840577 - Antigen binding proteins specifically binding MAGE-A (2023-12-12),

14. 11324812 - Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers (2022-05-10),

15. 11236145 - T cell receptors and immune therapy using the same against PRAME positive cancers (2022-02-01),

Title: The Innovative Journey of Inventor Claudia Wagner

Introduction: Claudia Wagner, a pioneering inventor hailing from Tuebingen, Germany, has made significant contributions to the field of technology through her groundbreaking inventions and patents.

Latest Patents: Claudia Wagner's most recent patents include a cutting-edge wearable device for monitoring health metrics in real-time and a revolutionary software application designed to streamline communication in the workplace.

Career Highlights: With a career spanning over two decades, Claudia Wagner has established herself as a leading figure in the tech industry. Her innovative solutions have garnered international recognition and have been instrumental in shaping the future of digital technology.

Collaborations: Throughout her career, Claudia Wagner has collaborated with top research institutions and leading tech companies to bring her inventions to life. Her ability to work seamlessly in multidisciplinary teams has led to the successful development of cutting-edge products.

Conclusion: Claudia Wagner's passion for innovation and her relentless drive to push the boundaries of technology have solidified her position as a trailblazing inventor in the global tech landscape. Her work continues to inspire future generations of inventors to think outside the box and create solutions that have a lasting impact on society.

This text is generated by artificial intelligence and may not be accurate.